8 Coupons
-
Special Offer
-
30% off
joe sanjo
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. why novartis� landmark cancer drug approval is great news for bluebird
.
.
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment.
.
see all results matching 'mub'
.why novartis� landmark cancer drug approval is great news for bluebird . .
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment. .
see all results matching 'mub'